Diaceutics PLC
Символ: DIUXF
PNK
1.3672
USDПазарна цена днес
-125.1411
Съотношение P/E
2.7906
Коефициент PEG
123.70M
MRK Cap
- 0.00%
Доходност на DIV
Diaceutics PLC (DIUXF) финансови отчети
Баланс
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |||
---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 75.44 | 19.8 | 19.7 | 25.3 | |||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | |||||||
balance-sheet.row.net-receivables | 36.1 | 10.4 | 10 | 7.8 | |||||||
balance-sheet.row.inventory | 0 | 0 | 0 | 0 | |||||||
balance-sheet.row.other-current-assets | 6.17 | 0.6 | 0.4 | 0.6 | |||||||
balance-sheet.row.total-current-assets | 117.71 | 30.9 | 30.1 | 33.6 | |||||||
balance-sheet.row.property-plant-equipment-net | 8.17 | 2.1 | 2.1 | 0.2 | |||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||
balance-sheet.row.intangible-assets | 62.41 | 15.2 | 12.8 | 9.4 | |||||||
balance-sheet.row.goodwill-and-intangible-assets | 62.41 | 15.2 | 12.8 | 9.4 | |||||||
balance-sheet.row.long-term-investments | -0.32 | 17.1 | 14.7 | 9.2 | |||||||
balance-sheet.row.tax-assets | 0.14 | 0 | 0 | 0.3 | |||||||
balance-sheet.row.other-non-current-assets | 0.64 | -17.1 | -14.7 | -9.2 | |||||||
balance-sheet.row.total-non-current-assets | 71.04 | 17.4 | 15 | 9.9 | |||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||
balance-sheet.row.total-assets | 188.75 | 48.3 | 45 | 43.5 | |||||||
balance-sheet.row.account-payables | 2.09 | 0.8 | 0.5 | 0.5 | |||||||
balance-sheet.row.short-term-debt | 0.25 | 0.1 | 0.3 | 0.1 | |||||||
balance-sheet.row.tax-payables | 0.85 | 0.4 | 0.3 | 0.8 | |||||||
balance-sheet.row.long-term-debt-total | 4.67 | 1.2 | 1.3 | 0 | |||||||
Deferred Revenue Non Current | 0 | 0 | -0.4 | 0 | |||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 1.05 | - | - | - | |||||||
balance-sheet.row.other-current-liab | 10.47 | 2.5 | 1.6 | 2 | |||||||
balance-sheet.row.total-non-current-liabilities | 7.1 | 2 | 1.7 | 0.4 | |||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||
balance-sheet.row.capital-lease-obligations | 5.18 | 1.3 | 1.4 | 0 | |||||||
balance-sheet.row.total-liab | 21.61 | 5.7 | 4.4 | 3.3 | |||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0.3 | 0 | |||||||
balance-sheet.row.common-stock | 0.68 | 0.2 | 0.2 | 0.2 | |||||||
balance-sheet.row.retained-earnings | 18.77 | 5.3 | 4.1 | 3.2 | |||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0.31 | 0.1 | -0.3 | 0 | |||||||
balance-sheet.row.other-total-stockholders-equity | 147.39 | 36.9 | 36.4 | 36.9 | |||||||
balance-sheet.row.total-stockholders-equity | 167.15 | 42.5 | 40.6 | 40.2 | |||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 188.75 | 48.3 | 45 | 43.5 | |||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||
balance-sheet.row.total-equity | 167.15 | 42.5 | 40.6 | 40.2 | |||||||
balance-sheet.row.total-liabilities-and-total-equity | 188.75 | - | - | - | |||||||
Total Investments | -0.32 | 17.1 | 14.7 | 9.2 | |||||||
balance-sheet.row.total-debt | 4.93 | 1.3 | 1.6 | 0.1 | |||||||
balance-sheet.row.net-debt | -70.52 | -18.5 | -18.1 | -25.1 |
Отчет за паричните потоци
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |||
---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0.01 | 0.6 | 0.5 | -0.7 | |||||||
cash-flows.row.depreciation-and-amortization | 4.61 | 3 | 1.8 | 0.8 | |||||||
cash-flows.row.deferred-income-tax | -8.21 | 1.3 | -0.5 | -0.7 | |||||||
cash-flows.row.stock-based-compensation | 0.55 | 0.5 | 0.4 | 0.3 | |||||||
cash-flows.row.change-in-working-capital | -2.78 | -0.3 | -1.7 | 0.5 | |||||||
cash-flows.row.account-receivables | -3.49 | -1.6 | -1.5 | 0.5 | |||||||
cash-flows.row.inventory | 0 | 0 | 0 | 0 | |||||||
cash-flows.row.account-payables | 0.71 | 1.3 | -0.2 | -0.1 | |||||||
cash-flows.row.other-working-capital | 0 | 0 | 0 | 0 | |||||||
cash-flows.row.other-non-cash-items | 10.82 | 0 | 0.1 | 0 | |||||||
cash-flows.row.net-cash-provided-by-operating-activities | 4.1 | 0 | 0 | 0 | |||||||
cash-flows.row.investments-in-property-plant-an-equipment | -5.53 | -4.9 | -5.6 | -6.3 | |||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | |||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | |||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | |||||||
cash-flows.row.other-investing-activites | -4.88 | 0.1 | 0 | 0 | |||||||
cash-flows.row.net-cash-used-for-investing-activites | -7.97 | -4.8 | -5.6 | -6.3 | |||||||
cash-flows.row.debt-repayment | -0.05 | 0 | -0.1 | 0 | |||||||
cash-flows.row.common-stock-issued | 0 | 0.1 | 0 | 19.6 | |||||||
cash-flows.row.common-stock-repurchased | -0.06 | -0.1 | -0.2 | 0 | |||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | |||||||
cash-flows.row.other-financing-activites | -0.25 | -0.2 | 0 | 0 | |||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -0.37 | -0.2 | -0.3 | 19.6 | |||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0.32 | 0 | -0.3 | 0 | |||||||
cash-flows.row.net-change-in-cash | -3.76 | 0.2 | -5.6 | 13.5 | |||||||
cash-flows.row.cash-at-end-of-period | 56.85 | 19.8 | 19.7 | 25.3 | |||||||
cash-flows.row.cash-at-beginning-of-period | 60.62 | 19.7 | 25.3 | 11.7 | |||||||
cash-flows.row.operating-cash-flow | 4.1 | 5.1 | 0.6 | 0.3 | |||||||
cash-flows.row.capital-expenditure | -5.53 | -4.9 | -5.6 | -6.3 | |||||||
cash-flows.row.free-cash-flow | -1.43 | 0.2 | -5 | -6 |
Ред за отчет за приходите
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |||
---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 32.85 | 19.5 | 13.9 | 12.7 | |||||||
income-statement-row.row.cost-of-revenue | 5.64 | 2.8 | 3.2 | 3.2 | |||||||
income-statement-row.row.gross-profit | 27.21 | 16.7 | 10.7 | 9.5 | |||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||
income-statement-row.row.selling-general-administrative | 20.88 | - | - | - | |||||||
income-statement-row.row.selling-and-marketing-expenses | 7.16 | - | - | - | |||||||
income-statement-row.row.other-expenses | 0 | 0 | 0 | 0 | |||||||
income-statement-row.row.operating-expenses | 28.02 | 16.2 | 10.2 | 9.7 | |||||||
income-statement-row.row.cost-and-expenses | 33.67 | 18.9 | 13.4 | 13 | |||||||
income-statement-row.row.interest-income | 0.5 | 0.1 | 0.1 | 0 | |||||||
income-statement-row.row.interest-expense | 0.1 | 0.1 | 0.1 | 0 | |||||||
income-statement-row.row.selling-and-marketing-expenses | 7.16 | - | - | - | |||||||
income-statement-row.row.total-other-income-expensenet | 0.42 | 0 | -0.1 | 0 | |||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||
income-statement-row.row.other-operating-expenses | 0 | 0 | 0 | 0 | |||||||
income-statement-row.row.total-operating-expenses | 0.42 | 0 | -0.1 | 0 | |||||||
income-statement-row.row.interest-expense | 0.1 | 0.1 | 0.1 | 0 | |||||||
income-statement-row.row.depreciation-and-amortization | 4.53 | 3 | 1.8 | 0.8 | |||||||
income-statement-row.row.ebitda-caps | 3.71 | - | - | - | |||||||
income-statement-row.row.operating-income | -0.82 | 0.6 | 0.6 | -0.7 | |||||||
income-statement-row.row.income-before-tax | -0.4 | 0.6 | 0.5 | -0.7 | |||||||
income-statement-row.row.income-tax-expense | 0.06 | -0.2 | -0.1 | -0.9 | |||||||
income-statement-row.row.net-income | 0.01 | 0.7 | 0.6 | 0.3 |
Често задавани въпроси
Какво е Diaceutics PLC (DIUXF) общи активи?
Diaceutics PLC (DIUXF) общите активи са 48256000.000.
Какъв е годишният приход на предприятието?
Годишните приходи са 14886000.000.
Какъв е маржът на печалбата на предприятието?
Маржът на печалбата на фирмата е -0.027.
Какъв е свободният паричен поток на компанията?
Свободният паричен поток е -0.027.
Какъв е маржът на нетната печалба на предприятието?
Маржът на нетната печалба е -0.027.
Какъв е общият приход на предприятието?
Общият приход е -0.061.
Каква е Diaceutics PLC (DIUXF) нетна печалба (нетен доход)?
Нетната печалба (нетният доход) е 724000.000.
Какъв е общият дълг на фирмата?
Общият дълг е 1329000.000.
Какъв е броят на оперативните разходи?
Оперативните разходи са 16166000.000.
Какъв е броят на паричните средства на фирмата?
Паричните средства на предприятието са 17880000.000.